A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Clinical trial NCT01303172 · COMPLETED
Trial details
- NCT number
- NCT01303172
- Sponsor
- Immodulon Therapeutics Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2014-06-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.